We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+3.43%
1 Year Est. Return
+15.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$132M
AUM Growth
+$75.3M
Cap. Flow
+$72.1M
Cap. Flow %
54.67%
Top 10 Hldgs %
4.8%
Holding
478
New
258
Increased
49
Reduced
17
Closed
154

Sector Composition

Rank Sector Weight
1 Technology 18.6%
2 Industrials 14.38%
3 Healthcare 14.34%
4 Consumer Discretionary 13.9%
5 Real Estate 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
201
SLB Ltd
SLB
$76.5B
$318K 0.24%
+6,479
New +$309K
HP icon
202
Helmerich & Payne
HP
$3.36B
$318K 0.24%
+8,958
New +$306K
AEO icon
203
American Eagle Outfitters
AEO
$2.98B
$317K 0.24%
+26,879
New +$335K
YOU icon
204
Clear Secure
YOU
$5.36B
$311K 0.24%
+13,443
New +$332K
CNXC icon
205
Concentrix
CNXC
$1.5B
$310K 0.24%
+3,841
New +$359K
T icon
206
AT&T
T
$167B
$310K 0.24%
19,439
+2,777
+17% +$47.3K
CMS icon
207
CMS Energy
CMS
$22.9B
$306K 0.23%
+5,217
New +$315K
RVLV icon
208
Revolve Group
RVLV
$1.84B
$306K 0.23%
+18,673
New +$348K
SGI
209
Somnigroup International
SGI
$15.3B
$303K 0.23%
+7,551
New +$284K
OABI icon
210
OmniAb
OABI
$294M
$301K 0.23%
59,794
-3,444
-5% -$14K
BMI icon
211
Badger Meter
BMI
$3.71B
$299K 0.23%
+2,025
New +$279K
EAF icon
212
GrafTech
EAF
$203M
$296K 0.22%
5,869
+2,504
+74% +$117K
RVNC
213
DELISTED
Revance Therapeutics, Inc.
RVNC
$294K 0.22%
+11,619
New +$362K
TFII icon
214
TFI International
TFII
$12B
$290K 0.22%
+2,544
New +$279K
IMMR icon
215
Immersion
IMMR
$256M
$288K 0.22%
+40,617
New +$301K
SHYF
216
DELISTED
The Shyft Group
SHYF
$287K 0.22%
+13,001
New +$305K
CTRE icon
217
CareTrust REIT
CTRE
$10.1B
$286K 0.22%
+14,384
New +$281K
KFY icon
218
Korn Ferry
KFY
$4.13B
$283K 0.21%
+5,711
New +$281K
CCJ icon
219
Cameco
CCJ
$38.9B
$282K 0.21%
+9,003
New +$253K
WTI icon
220
W&T Offshore
WTI
$492M
$281K 0.21%
+72,724
New +$313K
CRSP icon
221
CRISPR Therapeutics
CRSP
$4.6B
$281K 0.21%
+5,013
New +$284K
STKL
222
DELISTED
SunOpta
STKL
$281K 0.21%
+41,985
New +$316K
HUBG icon
223
HUB Group
HUBG
$2.93B
$279K 0.21%
6,958
+650
+10% +$25.1K
OSCR icon
224
Oscar Health
OSCR
$8.54B
$279K 0.21%
+34,604
New +$255K
CWEN icon
225
Clearway Energy Class C
CWEN
$5B
$270K 0.2%
+9,466
New +$286K

Similar funds

Nebula Research & Development's Q2 2023 Portfolio in Review

As of Q2 2023, Nebula Research & Development held 478 positions worth $132M, up 133% from $56.6M the previous quarter. Its ten largest holdings account for 4.8% of the portfolio.

Nebula Research & Development deployed $72.1M of net new capital in Q2 2023, opening 258 new positions and adding to 49 existing holdings. Its largest new stake was Victoria's Secret: 36,186 shares worth $631K.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was DNOW Inc, an estimated $185K trimmed.

  • Nebula Research & Development's largest Q2 2023 buy was Victoria's Secret: 36,186 shares worth $631K.
  • Nebula Research & Development added most to The Duckhorn Portfolio, Inc. in Q2 2023, an estimated $526K increase.
  • Nebula Research & Development's biggest Q2 2023 reduction was DNOW Inc, cutting an estimated $185K.
  • Nebula Research & Development fully exited Morningstar in Q2 2023, selling an estimated $324K.
  • Nebula Research & Development's ten largest holdings make up 4.8% of its $132M portfolio in Q2 2023.
  • Nebula Research & Development opened 258 new positions and closed 154 in Q2 2023.
  • Nebula Research & Development's portfolio value rose 133% quarter-over-quarter to $132M.

Based on Nebula Research & Development's 13F filing for Q2 2023, filed 14 Aug 2023.